<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Cyclosporine A is a lipophilic cyclic polypeptide used as an immunosuppressant drug for immunomodulation in transplant recipients. Oral dosing has limited effectiveness, because of its limited aqueous solubility, low intestinal permeation, and P-g efflux [
 <xref rid="B107-nutrients-11-00068" ref-type="bibr" class="xref">107</xref>]. Thus, researchers incorporated TPGS1000 in SEDDSs as an efflux inhibitor to increase the intestinal absorption of oral cyclosporine A [
 <xref rid="B108-nutrients-11-00068" ref-type="bibr" class="xref">108</xref>]. The optimized nanocarriers had good stability in simulated GI fluids. These SEDDSs had faster drug release and 4.5-fold greater oral bioavailability than the commercial product (Bioral
 <sup class="sup">Â®</sup>). The nephrotoxicity of these SEDDSs was negligible, based on measurements of blood urea nitrogen and plasma creatinine.
</p>
